AltMountain

Rmg-Kb Bioaccess Fund L.P.

New York, NY · CIK 1876080
Status: no Form D since Aug 2021. Funds file a Form D when they begin selling and amend it each year while the offering continues, so this fund has most likely stopped raising money. It may still be investing, or it may have closed or been dissolved. The details below are from its latest filing, kept here as a record.

Rmg-Kb Bioaccess Fund L.P. is a venture capital fund based in New York, New York. According to its most recent Form D, filed Aug 4, 2021, it has sold $61,224,490 of interests to 3 investors since its first sale in Jul 2021. The filing does not set a minimum investment. It relies on the Section 3(c)(1) exclusion, which limits it to 100 beneficial owners, typically accredited investors. The offering uses Rule 506(b), which does not permit general solicitation. Related persons named in the filing include LTD Rmg-Kb Bp Management.

Total raised
$61,224,490Cumulative sales reported on Form D
Investors
3
First sale
Jul 19, 2021
Minimum investment
None set
Who can invest
Accredited investorsSection 3(c)(1): up to 100 beneficial owners
Offering exemption
Rule 506(b)No general advertising
Key people and entities
LTD Rmg-Kb Bp Management
Latest Form D
Aug 4, 2021

From SEC filings, not verified. This page republishes the fund's Form D as filed. It is not an offer, solicitation or recommendation, and AltMountain has not reviewed the fund. “Raised” is cumulative sales, not current assets or performance. Returns are not part of SEC filings. Private funds are speculative, illiquid and generally limited to accredited investors or qualified purchasers. Full disclosures · Request a correction⁠​​‌‌‌‌‌‌‌‌​​​​​​​​​​⁠

Questions about Rmg-Kb Bioaccess Fund L.P.

What is the minimum investment for Rmg-Kb Bioaccess Fund L.P.?

Rmg-Kb Bioaccess Fund L.P.'s latest Form D, filed Aug 4, 2021, does not set a minimum investment. Managers can still require one in the offering documents.

Who can invest in Rmg-Kb Bioaccess Fund L.P.?

Rmg-Kb Bioaccess Fund L.P. is generally open only to accredited investors, and it may have no more than 100 beneficial owners because it relies on Section 3(c)(1). It uses Rule 506(b), which does not allow general advertising.

How much has Rmg-Kb Bioaccess Fund L.P. raised?

Rmg-Kb Bioaccess Fund L.P. reports $61,224,490 sold from 3 investors on its Form D filed Aug 4, 2021. This is cumulative sales since the offering began, not current assets or performance.

Where is Rmg-Kb Bioaccess Fund L.P. based?

Rmg-Kb Bioaccess Fund L.P. is based in New York, New York.

When did Rmg-Kb Bioaccess Fund L.P. launch?

Rmg-Kb Bioaccess Fund L.P. reports its first sale in Jul 2021.

Size compared with every venture capital fund

Raised more than 94% of the 1,245 venture capital funds based in New York, and more than 97% of all 14,877 that report sales.

More venture capital funds in New York

Similar-size venture capital funds in New York

All venture capital funds in New York